Showing results (161-170 of 202) with videos related to
Sort By:
Pageof 21
British Journal of Haematology|November 10, 2009
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)Gheath Alatrash, Maher Albitar, Susan O'Brien, et al.Cancer|April 4, 2006
Thalidomide therapy for myelofibrosis with myeloid metaplasiaDeborah A Thomas, Francis J Giles, Maher Albitar, et al.Cancer|December 12, 2003
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemiaSusan M O'Brien, Hagop M Kantarjian, Deborah A Thomas, et al.BMC Medical Genetics|November 17, 2010
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndromeWanlong Ma, Hagop Kantarjian, Ke Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic ModelInhye E Ahn, Xin Tian, David Ipe, et al.Blood|May 6, 2003
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndromeHesham M Amin, Iman Jilani, Elihu H Estey, et al.Archives of Pathology & Laboratory Medicine|July 8, 2011
Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimensAziza Nassar, Cynthia Cohen, Sally S Agersborg, et al.Cancers|April 13, 2024
Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell TransplantationScott D Rowley, Thomas S Gunning, Michael Pelliccia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndromeRazelle Kurzrock, Maher Albitar, Jorge E Cortes, et al.Pageof 21